Enliven (ELVN) is up 11.0%, or $3.92 to $39.45.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELVN:
- Enliven price target raised to $56 from $48 at H.C. Wainwright
- Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
- Video: Arm jumps as analysts react favorably to business model shift, guidance
- Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
- Enliven price target raised to $45 from $41 at Mizuho